BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6095077)

  • 1. Association of HTLV-III antibodies and cellular immune status of hemophiliacs.
    Tsoukas C; Gervais F; Shuster J; Gold P; O'Shaughnessy M; Robert-Guroff M
    N Engl J Med; 1984 Dec; 311(23):1514-5. PubMed ID: 6095077
    [No Abstract]   [Full Text] [Related]  

  • 2. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
    Muncunill J; Forteza A; Forner N; Forteza-Rei J
    Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
    [No Abstract]   [Full Text] [Related]  

  • 3. The prevalence of HTLV-III and HTLV-I antibodies in serum of hemophiliacs.
    De Rossi A; Dalla Gassa O; Chieco Bianchi L; Dal Bo Zanon R; Boscaro M; Girolami A
    Thromb Haemost; 1985 Dec; 54(4):897. PubMed ID: 3003957
    [No Abstract]   [Full Text] [Related]  

  • 4. Impairment of cellular immunity and OKT4 lymphocytes in symptom-free hemophiliacs with antibodies to human T leukemia virus III (HTLV III).
    Pandolfi F; De Rossi G; Mariani G; Carbonari M; Ensoli B; Napolitano M; Lopez M; Mandelli F; Aiuti F
    Diagn Immunol; 1985; 3(3):155-9. PubMed ID: 2996821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preventive measures against HTLV-III/LAV infections among hemophiliacs and their relatives].
    Evensen SA; Frøland SS; Glomstein A
    Tidsskr Nor Laegeforen; 1986 Jan; 106(1):19-21. PubMed ID: 3006278
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of HTLV-III/LAV antibodies in patients with hemophilia and in their sexual partners in France.
    Allain JP
    N Engl J Med; 1986 Aug; 315(8):517-8. PubMed ID: 3016541
    [No Abstract]   [Full Text] [Related]  

  • 7. [The occurrence of LAV/HTLV III antibodies in patients with hemophilia in the County of Funen].
    Larsen FS; Høst A; Munk-Andersen G
    Ugeskr Laeger; 1986 Mar; 148(14):865-7. PubMed ID: 3010526
    [No Abstract]   [Full Text] [Related]  

  • 8. HTLV-III antibody status in household contacts of seropositive hemophiliacs.
    Muntean W; Zenz W; Zaunschirm W; Teubl I; Heinz FX
    Blood; 1986 Jun; 67(6):1780-1. PubMed ID: 3011153
    [No Abstract]   [Full Text] [Related]  

  • 9. HTLV-III status and abnormalities in T lymphocyte distribution in children with hemophilia A.
    Shannon BT; Roach J; Cheek-Luten M; Ruymann FB
    Diagn Immunol; 1986; 4(1):37-42. PubMed ID: 3006971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of antibodies to human T-lymphotropic viruses type I and III in Japanese hemophiliacs.
    Koyanagi Y; Kobayashi S; Harada S; Kikukawa R; Yamamoto N; Watanabe K; Okino F; Kajii T
    AIDS Res; 1983-1984; 1(5):353-8. PubMed ID: 6100780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic.
    Evatt BL; Gomperts ED; McDougal JS; Ramsey RB
    N Engl J Med; 1985 Feb; 312(8):483-6. PubMed ID: 2982095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HTLV and immunosuppression.
    Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T
    Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-HTLV-III in hemophilic patients in Barcelona].
    Hernández Sánchez JM; Piqueras J; Vila M; Tusell J; Triginer J
    Sangre (Barc); 1985; 30(5):857-63. PubMed ID: 3003939
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics: a preliminary report.
    Lynn TC; Hsieh RP; Lin KT; Shen MC; Chen DS; Wang CH; Liu CH; Wang JH; Lai MY; Liou MF
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Aug; 17(3):172-6. PubMed ID: 6096089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to human T-cell leukemia virus type III in hemophiliacs from Spain.
    Kitchen L; Leal M; Wichmann I; Lissen E; Ollero M; Allan JS; McLane MF; Essex M
    Blood; 1985 Dec; 66(6):1473-5. PubMed ID: 2998515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemophiliacs and acquired immune deficiency syndrome.
    Lin TA; Zhao JQ; Rabin B
    Chin Med J (Engl); 1985 Jun; 98(6):444-6. PubMed ID: 2996841
    [No Abstract]   [Full Text] [Related]  

  • 17. HTLV-III/LAV-seronegative, virus-negative sexual partners and household contacts of hemophiliacs.
    McFadden T; Jason JM; Feorino P
    JAMA; 1986 Apr; 255(13):1702. PubMed ID: 3005673
    [No Abstract]   [Full Text] [Related]  

  • 18. Increase in prevalence of anti-HTLV-III in haemophiliacs.
    Gürtler LG; Wernicke D; Eberle J; Zoulek G; Deinhardt F; Schramm W
    Lancet; 1984 Dec; 2(8414):1275-6. PubMed ID: 6150304
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-HTLV-I antibody and anti-HIV antibody in hemophiliacs, patients with renal disease and blood donors].
    Kohno S; Masuyama Y; Dohtsu Y; Miyazaki T; Koga H; Yokoyama K; Taura K; Harada T; Yamaguchi K; Izumikawa K
    Kansenshogaku Zasshi; 1987 May; 61(5):567-73. PubMed ID: 2822821
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of HTLV-III/LAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX.
    Verani P; Mariani G; Mannucci PM; De Rossi G; Nicoletti L; Titti F; Falcione E; Pasqualetti D; Ammassari M; Gringeri A
    J Med Virol; 1986 Jun; 19(2):143-9. PubMed ID: 3014059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.